Member Info for researcher1

odd behaviour, driving the price down but restricting large buys. Final attempt to get cheap shares before serious move up?

not working out so far! so more for me at 63 to complete the order.

ok they've finally allowed me £1800 worth - I predict a rise today, let's see...

64 is half price, but typically the MMs will not let me buy - I've been trying on two platforms for the past 50 minutes...

thanks for that update - good to hear of the shift away from cobalt

there is still the cobalt issue - without enough of it, the lithium could be redundant...

"news sold into"? take a look at the chart and you'll see that's not the case, beyond perhaps the day of release. It did happen with the Swiss University RNS but the rise was overheated that afternoon. Cash could be an issue as FDA approaches, but I would expect there to be investors willing to come in at a premium, given the constant proof of product that we have witnessed.

bought a decent chunk of these today (thanks MMs for the early morning dip) - I was a shareholder a while ago but sold out due to slow progress. Today looks like the beginning of a better story - the higher margins are a crucial improvement, and all equipment is now owned, so costs should decline. It is still down to orders of course, but the year beginning looks very positive, and the temple may well become a repeat order. I'm in until 12p.

champagne is in order! even though we always knew P. would prove itself and could have drunk it 6 months ago...
Typical that the FDA want extras but, as AN says, it's great they have identified it now, rather than sending the application back (1 year delay, rather than 2 months).
Pop!

regarding manipulation - MMs certainly use the tree shake method, which we all know as those sudden drops to get investors to sell (both auto and manual), so they are certainly capable of non-demand-related manipulation. As you say, buyers can then step in, but the average p.i. probably waits until it has settled, so often a worthwhile gamble for the MMs, especially if they 'buy' some for themselves at the low point...

don't you just love tree shakes? it means the MMs are taking the share seriously again....

thanks for the reply - a similar story to my research (Glencore) into companies with exposure to mining in the Congo -not a place to put your house on....

my average is 31p, having first bought at 59p and then topped up as the sp fell. The calculation then was an sp of 120p (conservative estimate) at the start of production (you can see this scenario developing if you check the charts) rising threefold as the off-take grew, provided there were no issues. We had 30% dilution at 25p today (a bit disappointing, but better than 15p) so the equivalent (diluted) price expected is now 91.5p on production (now a certainty - amazing) rising to 270p. A good medium term play.
btw, Is anyone invested in Cobalt?

time to get these out of the bottom drawer it seems...

the 4.22 sell was me closing my 3.6p CFD - gotta claw back some profit somewhere....

as Jel says, just hold on, with FDA approval the floodgates will open.

you express what most LTH feel - that the BoD, LD excepted, are not pulling their weight BUT in this field science is king and quality will out (to use but a couple of cliches). LD's reputation is such that the company will be on the radar of many iis and the merest whiff of financial security (going forward) could lead to a stampede. GLA

good to see the recovery today - got stopped out on my CFD on Wed for an instant £1K loss (to add to 2 x 500 previously) but up £2K today so feeling much better. Paper losses on solid stock are alarming still... but...SP to double with FDA approval? (which is little to do with Scancell research...)

Pleased you are feeling better C7

nice rise today - didn't get my 72p, had to buy at 74 but that looks ok now....

I am a) c) and d) combined - confused, some might say. I sold all but 10% of Opti at 92 so am buying back in this week - would like 70p again but happy with 72.